Pediatrix Medical Group, Inc. (NYSE:MD – Get Free Report) has been given a consensus rating of “Hold” by the five brokerages that are currently covering the company, Marketbeat.com reports. Four analysts have rated the stock with a hold rating and one has given a buy rating to the company. The average 12-month price target among analysts that have issued a report on the stock in the last year is $10.90.
A number of research analysts have recently issued reports on MD shares. Truist Financial boosted their price objective on Pediatrix Medical Group from $10.00 to $13.00 and gave the company a “hold” rating in a research note on Monday, October 7th. Jefferies Financial Group raised Pediatrix Medical Group from a “hold” rating to a “buy” rating and raised their price objective for the company from $8.00 to $14.00 in a research note on Thursday, September 26th. UBS Group upped their target price on Pediatrix Medical Group from $9.00 to $10.50 and gave the stock a “neutral” rating in a research report on Friday, August 9th. Finally, StockNews.com raised shares of Pediatrix Medical Group from a “sell” rating to a “hold” rating in a research report on Wednesday, August 7th.
Read Our Latest Report on Pediatrix Medical Group
Insiders Place Their Bets
Institutional Inflows and Outflows
Several large investors have recently bought and sold shares of MD. Rubric Capital Management LP raised its holdings in Pediatrix Medical Group by 797.0% in the second quarter. Rubric Capital Management LP now owns 8,150,000 shares of the company’s stock worth $61,532,000 after buying an additional 7,241,400 shares during the last quarter. Dana Investment Advisors Inc. grew its position in Pediatrix Medical Group by 80.3% during the second quarter. Dana Investment Advisors Inc. now owns 1,023,136 shares of the company’s stock valued at $7,725,000 after buying an additional 455,785 shares during the period. Boston Partners boosted its position in shares of Pediatrix Medical Group by 34.0% in the first quarter. Boston Partners now owns 1,786,434 shares of the company’s stock worth $17,702,000 after purchasing an additional 453,254 shares during the period. Cubist Systematic Strategies LLC lifted its holdings in shares of Pediatrix Medical Group by 639.4% in the second quarter. Cubist Systematic Strategies LLC now owns 290,336 shares of the company’s stock worth $2,192,000 after buying an additional 251,072 shares in the last quarter. Finally, ClariVest Asset Management LLC purchased a new position in shares of Pediatrix Medical Group in the second quarter worth $1,721,000. 97.71% of the stock is owned by hedge funds and other institutional investors.
Pediatrix Medical Group Stock Down 2.7 %
Shares of NYSE:MD opened at $12.55 on Thursday. The company has a market capitalization of $1.06 billion, a price-to-earnings ratio of -14.76, a P/E/G ratio of 1.98 and a beta of 1.56. The company has a debt-to-equity ratio of 0.87, a current ratio of 1.38 and a quick ratio of 1.38. The business’s 50-day moving average is $11.31 and its 200-day moving average is $9.23. Pediatrix Medical Group has a 1 year low of $6.62 and a 1 year high of $12.99.
Pediatrix Medical Group (NYSE:MD – Get Free Report) last announced its quarterly earnings data on Tuesday, August 6th. The company reported $0.34 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.31 by $0.03. The company had revenue of $504.30 million for the quarter, compared to the consensus estimate of $505.49 million. Pediatrix Medical Group had a positive return on equity of 10.59% and a negative net margin of 12.58%. The firm’s revenue was up .7% compared to the same quarter last year. During the same period in the previous year, the business earned $0.37 EPS. Equities research analysts predict that Pediatrix Medical Group will post 1.19 earnings per share for the current year.
About Pediatrix Medical Group
Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.
Featured Articles
- Five stocks we like better than Pediatrix Medical Group
- 10 Best Airline Stocks to Buy
- Chinese Stocks Cool Off: Time to Buy the Dip in These 2 Stocks?
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Goldman Sachs Highlights 3 Top Short Squeeze Stocks to Watch
- Roth IRA Calculator: Calculate Your Potential Returns
- Walmart is Up 56% YTD, Is it Still a Top Consumer Staples Stock?
Receive News & Ratings for Pediatrix Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pediatrix Medical Group and related companies with MarketBeat.com's FREE daily email newsletter.